Yersinia pseudotuberculosis Spatially Controls Activation and Misregulation of Host Cell Rac1 by Wong, Ka-Wing & Isberg, Ralph R
Yersinia pseudotuberculosis Spatially
Controls Activation and Misregulation
of Host Cell Rac1
Ka-Wing Wong
1, Ralph R. Isberg
1,2*
1 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America, 2 Howard Hughes Medical
Institute, Tufts University School of Medicine, Boston, Massachusetts, United States of America
Yersinia pseudotuberculosis binds host cells and modulates the mammalian Rac1 guanosine triphosphatase (GTPase) at
two levels. Activation of Rac1 results from integrin receptor engagement, while misregulation is promoted by
translocation of YopE and YopT proteins into target cells. Little is known regarding how these various factors interplay
to control Rac1 dynamics. To investigate these competing processes, the localization of Rac1 activation was imaged
microscopically using fluorescence resonance energy transfer. In the absence of translocated effectors, bacteria
induced activation of the GTPase at the site of bacterial binding. In contrast, the entire cellular pool of Rac1 was
inactivated shortly after translocation of YopE RhoGAP. Inactivation required membrane localization of Rac1. The
translocated protease YopT had very different effects on Rac1. This protein, which removes the membrane localization
site of Rac1, did not inactivate Rac1, but promoted entry of cleaved activated Rac1 molecules into the host cell nucleus,
allowing Rac1 to localize with nuclear guanosine nucleotide exchange factors. As was true for YopE, membrane-
associated Rac1 was the target for YopT, indicating that the two translocated effectors may compete for the same pool
of target protein. Consistent with the observation that YopE inactivation requires membrane localization of Rac1, the
presence of YopT in the cell interfered with the action of the YopE RhoGAP. As a result, interaction of target cells with a
strain that produces both YopT and YopE resulted in two spatially distinct pools of Rac1: an inactive cytoplasmic pool
and an activated nuclear pool. These studies demonstrate that competition between bacterial virulence factors for
access to host substrates is controlled by the spatial arrangement of a target protein. In turn, the combined effects of
translocated bacterial proteins are to generate pools of a single signaling molecule with distinct localization and
activation states in a single cell.
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Introduction
After ingestion by a host, Yersinia pseudotuberculosis gains a
foothold in intestinal lymph nodes by moving across M cells
into Peyer’s patches [1]. As is true for the closely related Y.
enterocolitica, entry into regional lymph nodes in the ﬁrst few
hours after infection requires the bacterial outer membrane
protein invasin [2,3], which binds multiple b1 integrin
receptors [1,4]. The preferential targeting of enteropatho-
genic Yersinia into M cells may be a consequence of speciﬁcity
for these receptors, as no other cell type presents the
appropriate integrin receptors on the intestinal lumen [5].
The importance of invasin for causing localized disease and
colonizing within the intestine is well established [6], although
the protein may be dispensable once bacteria establish
infection in deep tissues [7,8].
Invasin-mediated uptake by cultured cells involves inter-
nalization of bacteria into membrane-bound compartments
[9]. This adhesion event initiates actin rearrangements [4]
controlled by the small guanosine triphosphatase (GTPase)
Rac1 [10,11]. Rac1 is a member of the Rho GTPase family that
controls a number of actin-dependent events, such as cell
rufﬂing, motility, phagocytosis, and synapse formation [10–
12]. Polyvalent engagement of integrin receptors by invasin
results in activation of Rac1, with immediate loading of GTP
into Rac1, although the site within the cell that harbors the
activated Rac1 is not known [10]. The details that link
integrin engagement to Rac1 activation are also unclear,
although it has been argued that during integrin adhesion
events, GTP loading produces a signal that releases cytosolic
Rac1 from the protein Rho GDP-dissociation inhibitor
(RhoGDI) [13]. Similarly unclear are the molecular details of
how Rac1 coordinates the cytoskeletal rearrangements
necessary for invasin-mediated uptake. Overproduction and
localization studies argue that actin dynamics promoted by
Arp2/3 and the lipid phosphoinositol-4,5-phosphate, as well
as the small GTPase Arf6, are players downstream from Rac1
during uptake [14].
Yersinia species also target Rac1 for inactivation by several
translocated effector proteins delivered by a type III
secretion system, so the dynamics of Rac1 nucleotide loading
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of these effectors, YopE and YopT, interfere with the
function of multiple Rho family members through distinct
mechanisms. YopE is a GTPase-activating protein for Rho
family members (RhoGAP) [16,17]. The primary consequence
of the RhoGAP activity of YopE is to interfere with a wide
variety of phagocytic events, including invasin-mediated
uptake. Pseudomonas aeruginosa ExoS and Samonella typhimurium
SptP RhoGAP proteins have been shown to have similar
functions [18,19]. Another translocated effector that inhibits
invasin-mediated uptake is YopT, which is a cysteine protease
that cleaves upstream of the prenylated cysteine within the
CAAX motif at the C terminus of Rho family members Cdc42,
Rac1, and RhoA [20]. Although puriﬁed YopT protein from Y.
pestis does not appear to show speciﬁcity for individual Rho
family members, YopT proteins from different species of
Yersinia may not behave identically. For instance, the Y.
enterocolitica protein targets only RhoA after its translocation
into macrophages [21]. The substrate speciﬁcity of YopT in Y.
pseudotuberculosis-infected cells is not known. Also unknown
are the consequences of YopT cleavage on the activation state
of Rho family members [22].
Enteropathogenic Yersinia species transmit potentially
conﬂicting signals to Rho GTPases that may accommodate
speciﬁc requirements during establishment of disease. To
study these signals, we analyzed the response of Rac1 to
adhesion by Y. pseudotuberculosis. We found that intracellular
localization of Rac1 controls the ability of the bacterium to
manipulate activation of this regulatory molecule.
Results
Use of Fluorescent Resonance Energy Transfer
Measurements to Monitor Rac1 Activation
Several strategies based on ﬂuorescence resonance energy
transfer (FRET) have been described to visualize Rac1
activation [23–25]. To determine the consequences of Y.
pseudotuberculosis infection on Rac1 activation in host cells, we
developed a strategy similar to that reported previously [23],
in which the loading of GTP into Rac1 was localized to
speciﬁc sites in the mammalian cell using ﬂuorescence
microscopy. Activated (GTP-loaded) Rac1 can be distin-
guished from the rest of the Rac1 pool in the cell by its
ability to bind the effector domain of PAK1 (residues 67–118
from p21-associated kinase, called p21-binding domain
[PBD]). In cells transfected with CFP-tagged Rac1, binding
by the GTP-loaded form of Rac1 to YFP-tagged PBD was
measured by intermolecular ﬂuorescent resonance energy
transfer from the CFP moiety to the YFP moiety after 440 nm
excitation (Figure 1A). As YFP and CFP can dimerize and
generate a FRET signal, monomeric derivatives of these
proteins were used (called mCFP and mYFP) [26]. Throughout
the work, sensitized FRET is deﬁned as the total amount of
FRET in a deﬁned region of interest, using the appropriate
corrections from images captured by ﬂuorescence micro-
scopy (Materials and Methods). Normalized FRET is the ratio
of sensitized FRET divided by the total amount of a
ﬂuorophore (usually mCFP-Rac1) in a region of interest
(Materials and Methods). Except where noted, we excluded
the nuclear pool of Rac1 in the analysis of mCFP-Rac1
activation.
To determine if GTP loading was the speciﬁc readout of
this system, a series of mutant Rac1 and PBD derivatives were
transfected into COS1 cells in the absence of incubation with
Y. pseudotuberculosis (Table 1). The constitutively active mCFP-
Rac1V12 (GTP-bound, Table 1) generated substantial FRET,
as predicted for a protein that does not require external
activation (Figure 1B and 1C). GTP loading of Rac1 was
required to detect a signal, because no sensitized FRET was
observed in cells cotransfected with the dominant negative
mCFP-Rac1N17 and mYFP-PBD (Figure 1B). The intensity of
sensitized FRET observed was a function of the concentration
of mCFP-Rac1 (mCFP-Rac1 intensity; Figure 1C) and mYFP-
PBD (unpublished data) in individual transfectants. Cells
cotransfected with mCFP-Rac1 wild-type (WT) and mYFP-
PBD produced FRET at an expected lower efﬁciency than
Rac1V12, based on the levels of FRET normalized to the
concentration of Rac1 (Figure 1C and 1D), as only a portion
of the Rac1 pool would be predicted to be GTP loaded in
these cells. Consistent with the FRET observed being due to
direct binding of PBD to Rac1 rather than simple colocaliza-
tion of the two proteins, we found that no FRET was observed
when the PBD binding-defective mCFP-Rac1C40 (Table 1)
was cotransfected with mYFP-PBD (Figure 1B). Furthermore,
no FRET was observed when a mutant mYFP-PBD defective
in binding to activated Rac1 (PBD-LL; Table 1) was analyzed
(Figure 1B). Thus, sensitized FRET measurements monitored
the activation status of Rac1 as well as the concentration of
Rac1 and its effector PBD in a single cell, and the controls are
consistent with FRET resulting from direct binding of Rac1 to
effector.
To give further support to the hypothesis that FRET was
due to binding of Rac1-GTP to PBD, photobleaching was
performed (Figure 1E). When activated mCFP-Rac1 binds
mYFP-PBD, the mYFP acceptor absorbs a fraction of the
ﬂuorescence emission from the mCFP donor, resulting in lost
mCFP emission. The lost mCFP emission can be restored by
destroying the mYFP ﬂuorophore via photobleaching (Mate-
rials and Methods) [27]. As expected, cells cotransfected with
mCFP-Rac1(WT) and mYFP-PBD resulted in a 10% increase
in mCFP emission after photobleaching of mYFP-PBD
(Figure 1E). Photobleaching of the mYFP-PBD acceptor
resulted in an even higher enhancement of mCFP-Rac1V12
emission (16%). Identical photobleaching treatments, how-
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Synopsis
Many disease-causing bacteria transfer proteins into host cells,
interfering with defense against infections. Bacteria often do this by
manipulating host proteins that send signals. This study analyzes
how one such bacterial pathogen manipulates the host signaling
protein Rac1. The proteins YopT and YopE, which are made by
several pathogens, including the agent of bubonic plague, had been
presumed to inactivate Rac1. The authors show here that this model
is too simple, and that pathogens are able to both inactivate and
maintain activation of a host protein in a single cell. In this work, the
pathogen divides up the Rac1 population into two pools, each with
different potentials to send signals. One pool is found in the host
cell cytoplasm and is unable to function properly. The other pool of
Rac1 is sent into the nucleus, where it still sends an appropriate
signal. Therefore, a bacterial pathogen is shown to allow signaling
from one site in the host cell, while preventing it from occurring at a
different site. Such locale-dependent events within single cells were
not previously thought to play a role in microbial pathogenesis.Figure 1. Activation of Rac1 in Single Cells as Demonstrated by FRET
(A) Schematic representation of intermolecular FRET from Rac1-GTP to PBD. In the absence of GTP loading, mCFP-Rac1 is unable to bind mYFP-PBD.
Upon GTP loading (activation) of Rac1, mCFP-Rac1-GTP is able to bind to the downstream effector construction mYFP-PBD. This allows the emission
from mCFP to excite mYFP, resulting in emission at 527 nm.
(B) Display of fluorescence emission and sensitized FRET in individual transfectants. COS1 cells cotransfected with various mCFP-Rac1 derivatives and
either mYFP-PBD or mYFP-PBD(LL) were subjected to FRET analysis, and sensitized FRET was calculated (Materials and Methods). Displayed are the
channels for CFP and YFP emission as well as the relative Rac1 activation throughout the cell as determined by sensitized FRET. The color-scale bar
represents the amount of Rac1 activation displayed as relative pixel intensity in noted area of cell (Materials and Methods). White bar represents 10 lm.
(C) FRET is dependent on coexpression of active mCFP-Rac1 and mYFP-PBD. FRET from ten ROIs, which represented two cytoplasmic regions from each
of five cells, were plotted as a function of the intensity of the mCFP-Rac1 donor.
(D) Activation of Rac1 increases normalized levels of FRET. Data from (C) were normalized to amount of mCFP-Rac1 in each region of interest and
displayed. Displayed are means 6 standard errors of the mean (SEMs)
(E) Enhanced emission of the mCFP-Rac1 donor resulting from acceptor photobleaching requires Rac1 activation. The acceptor mYFP-PBD was
selectively photobleached for 2 min, and amount of mCFP-Rac1 donor emission was compared before and after irradiation (Materials and Methods). The
percentage increase in emission of after irradiation is displayed. To determine emission enhancement, ten ROIs were analyzed. Displayed are means 6
SEMs.
DOI: 10.1371/journal.ppat.0010016.g001
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Spatial Modulation of Rac1 by Yersiniaever, had almost no effect on the emission intensities of the
nonbinding mCFP-Rac1N17 or mCFP-Rac1C40 mutants
(Figure 1E). Similarly, no enhancement of mCFP-Rac1
emission was observed after photobleaching of mYFP-
PBD(LL), consistent with the fact that this protein is defective
for interaction with activated Rac1. Therefore, by two
different criteria we can detect speciﬁc binding of mYFP-
PBD to Rac1-GTP.
GTP-Loaded Rac1 Is Recruited to Nascent Phagosomes
Rac1 is activated after engagement of integrin receptors by
Y. pseudotuberculosis [10]. This could occur as either global
activation of the entire Rac1 pool or localized changes in
Rac1 conformation at regions proximal to the nascent
phagosome. To distinguish between these possibilities, FRET
analysis was performed after 20 min incubation of Y.
pseudotuberculosis with COS1 cells. The Y. pseudotuberculosis
strain used for these infections lacked the Yersinia virulence
plasmid and was grown under conditions in which the invasin
protein was the only adhesin expressed, so that all effects
observed were a consequence of invasin engagement of
receptors. When ﬁxed samples were stained to identify
partially internalized bacteria (Figure 2; see Materials and
Methods), the mCFP-Rac1(WT) recruited around nascent
phagosomes showed concentrated levels of activation (Sensi-
tized FRET, Figure 2A; WT, Figure 2E). This could result from
either simple recruitment of mCFP-Rac1 or the presence of a
pool of mCFP-Rac1 localized around the phagosomes that is
more highly activated than pools found elsewhere in the cell.
To distinguish between these possibilities, the amount of
activated mCFP-Rac1 was normalized to the concentration of
mCFP-Rac1 at speciﬁc points within the cell. When this was
taken into account, it was clear that the mCFP-Rac1
associated with both the nascent phagosomes and the cell
periphery was in a more highly active state then pools found
elsewhere in the cell (Normalized FRET, Figure 2A; WT,
Figure 2F; p , 0.006). In contrast, although active mCFP-
Rac1V12 was concentrated around nascent phagosomes
(Sensitized FRET, Figure 2B; V12, Figure 2E), no enhanced
activity could be observed around entering bacteria relative
to other sites in the cell, as there was active mCFP-Rac1V12
throughout the cell (Normalized FRET, Figure 2B; V12, Fig-
ure 2F). The mCFP-Rac1N17 derivative, which fails to load
GTP, showed no enhanced activation (Figure 2C), while the
mCFP-Rac1C40 mutant that fails to bind PBD also produced
no FRET with mYFP-PBD (Figure 2D). As mCFP-Rac1C40 is
localized around nascent phagosomes, this demonstrates that
mere concentration of mCFP-Rac1 around the phagosome is
not sufﬁcient to generate a FRET signal. These data indicate
that invasin binding to host cells results in a clear concen-
t r a t i o no fR a c 1i nt h ea c t i v a t e df o r ma tt h en a s c e n t
phagosome.
Selective Inactivation of Membrane-Targeted Rac1 by
YopE
The ability to localize activated Rac1 to speciﬁc sites within
target cells facilitated spatial analysis of the targeting of Rac1
by Yersinia translocated effectors, allowing investigation of
the consequences of YopE RhoGAP activity (Figure 3) [16,17].
Using a strain that expresses invasin and YopE (YP17/pYopE,
Materials and Methods) but lacks the effectors YopT and the
tyrosine phosphatase YopH, there was little GTP-loaded
mCFP-Rac1 in target cells (Figure 3A and 3C). To determine
whether the cytosolic or membrane pools of Rac1 were
inactivated, two Rac1 mutants were analyzed that have
altered localization properties. The Rac1R66A mutant (Table
1) does not bind to RhoGDI, and because RhoGDI is required
to extract Rac1 from the membrane, the mutant protein
localizes in the membrane [28]. The second mutant,
Rac1C189S, does not undergo prenylation of the cysteine
required for membrane localization, and remains soluble.
When regions of interest (ROIs) within the cytoplasm of cells
having bound Y. pseudotuberculosis were analyzed, it was clear
that cytosolic mCFP-Rac1C189S remained active after YopE
translocation (Figure 3B and 3C). The entire pool of the
membrane-localized mCFP-Rac1R66A, in contrast, appeared
to be inactivated (Figure 3B and 3C). Therefore, although
YopE rapidly inactivates Rac1, it does so by selectively
targeting membrane-associated Rac1. Presumably, the inacti-
vation of mCFP-Rac1(WT) was due to YopE inactivation of
membrane-associated protein, followed by translocation of
any soluble pools of GTP-loaded mCFP-Rac1(WT) to the
plasma membrane, and then further cycles of inactivation.
The Y. pseudotuberculosis YopT Removes Multiple Rho
Family Members from Nascent Phagosomes
We next wished to analyze the interplay between YopE and
another translocated effector that targets Rac1 in vitro. Both
YopE and YopT inhibit uptake of enteropathogenic Yersinia
species (unpublished data) [17], although it is not clear that
YopT targets Rac1 in intact cells. It has been previously
reported that the Y. enterocolitica YopT cysteine protease
Table 1. Predicted Properties of Fluorescent Proteins Used in this Study
Protein Allele Properties Predicted Conditions for Rac1-PBD Binding Localization
mYFP-PBD Binds Rac1-GTP After Rac1 activation Cytoplasm
mYFP-PBD(LL) Defective for Rac1 binding No binding Cytoplasm
mCFP-Rac1(WT) WT After Rac1 activation Cytoplasm and membrane
mCFP-Rac1V12 GTP hydrolysis defective Constitutive Cytoplasm and membrane
mCFP-Rac1N17 No loading of GTP No binding Membrane
mCFP-Rac1C40 Defective effector binding site No binding Cytoplasm and membrane
mCFP-Rac1C189S Missing prenylation site After Rac1 activation Nucleus and cytoplasm
mCFP-Rac1R66A Defective for RhoGDI binding After Rac1 activation Predominantly membrane
mCFP-Rac1(6Q) Missing Rac1 polybasic region After Rac1 activation Cytoplasmic
DOI: journal.ppat.0010016/journal.ppat.0010016.t001
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Spatial Modulation of Rac1 by Yersiniaselectively releases RhoA from the plasma membrane of
target cells, inhibiting bacterial uptake [21]. This conﬂicts
with analysis of Y. pseudotuberculosis indicating that cells having
inactivated RhoA support invasin-dependent internalization,
so presumably Y. pseudotuberculosis YopT must target another
Rho family member [17].
To investigate the possibility that Y. pseudotuberculosis YopT
also targeted Rac1 and Cdc42, we examined localization of
Rho family members about the nascent phagosome (Figure 4).
The three Rho family members RhoA, Cdc42, and Rac1 were
recruited to nascent phagosomes in a strain lacking YopT,
YopH, and YopE (YP17; Figure 4A and 4C). In contrast, all
three Rho family members were depleted from partially
formed phagosomes after 30 min of contact with the identical
Y. pseudotuberculosis strain expressing YopT (Figure 4B and
4D). The percentage of adherent bacteria associated with
each small GTPase in the presence of YopT was as low as that
observed with Rac1C189S, which lacks a geranylgeranyl
moiety to localize it on plasma membrane. In contrast, Arf6
localization [14,29] was not affected by YopT treatment,
showing that the phagosomal membrane was not disrupted by
YopT (Figure 4B and 4D). Therefore, at least in the case of Y.
pseudotuberculosis, there does not appear to be striking
substrate speciﬁcity for various Rho family members.
Rac1 has a strong nuclear localization signal in the
polybasic domain located immediately upstream of the CAAX
prenylation motif [22]. YopT-promoted cleavage should
release the prenylation motif and liberate a truncated Rho
family member that contains the intact nuclear localization
[20]. After 30 min of YopT translocation from adherent Y.
pseudotuberculosis, there was intense nuclear accumulation of
Rac1 (69% of cells showed nuclear localization, n¼36; Figure
4E), which was similar in intensity to that observed for the
Rac1C189S mutant (Figure 4E). This contrasts with the
control incubation with bacteria that fail to express YopT
(7.7% of cells showed nuclear localization, n¼39). Consistent
with the importance of the polybasic region for this
localization result, we observed no nuclear accumulation by
the Rac16Q mutant (Table 1) in which the polybasic region
was disrupted by replacement with six Gln residues (Figure
4E). These results indicate that removal of the prenylated
cysteine by YopT induces Rac1 nuclear localization.
As observed for YopE, membrane-associated Rac1 was the
target of YopT. Bacterial translocation of YopT failed to
result in nuclear accumulation of the cytoplasmically
localized Rac16Q (unpublished data). Furthermore, if Rac1
were localized in a cytoplasmic pool as a result of over-
production of RhoGDI, then YopT-promoted nuclear accu-
mulation of Rac1 was blocked (Figure 4F). Therefore, both
YopE and YopT targeted the identical membrane-associated
fraction of Rac1, and potentially can compete for the same
pool of Rac1.
YopT Cleavage Does Not Block Rac1 Activation
Based on the biochemical properties of the Yersinia
effectors, YopE disrupts function by preventing Rac1
activation, whereas YopT simply mislocalizes Rac1. It is
possible, however, that the altered localization of Rac1 that
results from YopT proteolysis also interferes with GTP
loading. For this reason, we examined whether Rac1
mislocalization results in its inactivation, using the Y.
pseudotuberculosis strain that expresses YopT as the only
Figure 2. Localized Activation of Rac1 on the Phagosomal Membrane
during Y. pseudotuberculosis Uptake
(A–D) Transfected COS1 cells were incubated with Y. pseudotuberculosis
(YPIII[P
 ]) for 20 min, fixed, and then immunostained with anti-Y.
pseudotuberculosis to detect partially internalized bacteria (Extracellular
bacteria; see Materials and Methods). Rac1 activation was measured by
sensitized FRET, and normalization (Normalized FRET) was performed by
determining the amount of FRET at each pixel relative to the mCFP-Rac1
intensity at that pixel (Materials and Methods). Color-gradient scales, as
described in Figure 1, were used to represent the intensity of signal for
Rac1 activation (Sensitized FRET) as well as for normalized Rac1
activation (Normalized FRET). Note the scales are not identical in each
window. Arrows indicate nascent phagosomes, as described (Materials
and Methods), and these are simultaneously displayed in insets. Shown
are cotransfection of: mCFP-Rac1(WT) and mYFP-PBD (A), constitutively
active mCFP-Rac1V12 with mYFP-PBD (B), dominant negative mCFP-
Rac1N17 with mYFP-PBD (C), and effector binding-defective mCFP-
Rac1C40 with mYFP-PBD (D). White bar represents 10 lm.
(E) FRET in response to Y. pseudotuberculosis adhesion is dependent on
coexpression of active mCFP-Rac1 and mYFP-PBD. Sensitized FRET (Rac1
activation) at regions surrounding nascent phagosomes was plotted as a
function of the intensity of the mCFP-Rac1 donor in the cell.
(F) The pool of Rac1 surrounding incoming bacteria is preferentially
activated. The intensity of FRET that surrounded nascent phagosomes
was compared to that found in nearby cytoplasmic areas, normalized
against the concentration of mCFP-Rac1 found in each area, and then
used to calculate the ratio of normalized Rac1 activity of nascent
phagosome to that of background (Materials and Methods). Data from
20 nascent phagosomes in cells expressing mYFP-PBD along with either
mCFP-Rac1(WT) or mCFP-Rac1V12 were displayed as mean 6 SEM (p ¼
0.006).
DOI: 10.1371/journal.ppat.0010016.g002
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Spatial Modulation of Rac1 by Yersiniaknown translocated effector that alters Rac1 function. After
30 min of incubation with YP17/pYopT, transfected cells
exhibited intense nuclear accumulation of mCFP-Rac1,
indicating that most of the Rac1 was cleaved (Figure 5A).
Despite this altered localization, there were high levels of
GTP-loaded Rac1 (Figure 5B), which may have been activated
by exchange factors known to localize in the nucleus, such as
SmgGDS and Dock180 [22,30]. The highly concentrated
mCFP-Rac1 in the nuclear region and the less highly
concentrated pool in peripheral regions of the cell had
similar levels of activation when normalized to the amount of
mCFP-Rac1 in these regions (Figure 5A and unpublished
data). The action of translocated YopT on Rac1(WT)
mimicked the behavior of Rac1C189S in uninfected cells, as
this derivative had similar activation levels compared to
transfectants harboring mCFP-Rac1(WT) (Figure 5C–5E).
Therefore, prenylation of Rac1 was not required for GTP-
loading and effector binding of Rac1 in this system. In
addition, in the absence of YopE, the primary role of YopT is
to disrupt the localization of Rac1 without affecting its
activation.
The Combined Action of YopE and YopT Generate Two
Different Pools of Rac1
The above results indicate that the nonprenylated form of
Rac1 is a poor substrate for YopE. Therefore, the removal of
prenylation by YopT should protect a pool of Rac1 from
inactivation by YopE, and that pool should move into the
nucleus. To test this prediction, a strain expressing both
YopE and YopT was used to challenge COS1 cells, and levels
Figure 3. YopE Selectively Inactivates Membrane-Associated Rac1.
COS1 cells cotransfected with plasmids expressing mYFP-PBD and noted plasmids were challenged at 37 8C for 30 min with Y. pseudotuberculosis
YP17(yopH
 , yopT
 , yopE
 ) (noted as ‘‘Control’’ in [A] and [B]) or YP17/pYopE (noted as ‘‘þYopE’’ in [A–C]). Bacteria were grown at 37 8C for 1 h to
induce expression of the type III secretion system prior to infection (Materials and Methods). The C189S mutation blocks plasma membrane localization
of Rac1, whereas R66A prevents extraction of Rac1 by RhoGDI from plasma membrane into cytosol.
(A and B) Displayed are images of typical cells showing phase contrast, mCFP fluorescence and color-scaled sensitized FRET or normalized (Rac1
activation) for YP17 (A) or Yp17/pYopE (A and B) infected cells (Materials and Methods). White bar represents 10 lm.
(C) Cytoplasmic Rac1 is not a YopE target. Normalized FRET was determined (Materials and Methods) by imaging cytoplasm of eight infected cells
(Materials and Methods). Data for mCFP-Rac1 activation was normalized against mCFP-Rac1 intensity (normalized Rac1 activation) and displayed as
mean 6 SEM. *****, p , 5310
 6 between control cells and YopE-treated cells or between Rac1(WT) and Rac1C189S-transfected cells. NS, no significant
difference between Rac1(WT)-transfected cells and Rac1R66A-transfected cells.
DOI: 10.1371/journal.ppat.0010016.g003
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Spatial Modulation of Rac1 by Yersiniaof Rac1 activation were compared to the parental strain
lacking YopT (Figure 6). As the YPIII strain does not encode
YopT, a plasmid expressing YopT was introduced into the
strain (YP15/pYopT). YopT clearly interfered with the action
of YopE (Figure 6A), with the level of cytoplasmic FRET
approaching that observed in cells incubated with bacteria
lacking YopE (Figure 6B), and it caused accumulation of
activated Rac1 in the nucleus (Figure 6C). It appeared,
however, that persistent activation of Rac1 under these
conditions was probably due to overexpressed YopT blocking
YopE translocation into COS1 cells. When translocation was
analyzed using a standard detergent solubilization strategy
[31], the strain expressing both proteins (YP15/pYopT; Figure
6D) showed barely detectable YopE translocation, with levels
only slightly above those in strains lacking the type III
secretion system (yscU, Figure 6D).
To directly study the effects of simultaneous deposition of
YopT and YopE on Rac1 dynamics without changing trans-
location rates, two alternate strategies were pursued. First,
strains expressing only YopT (‘‘T,’’ Figure 7) or YopE (‘‘E,’’
Figure 7) were simultaneously incubated with COS1 cells.
Second, Rac1 dynamics were analyzed after incubation of
COS1 cells with the recently sequenced clinical isolate
IP32953 encoding both YopT and YopE on the Yersinia
virulence plasmid [32]. Coinfection of the YopE- and YopT-
expressing strains resulted in a strong reduction in cyto-
plasmically localized Rac1 activation relative to a strain
lacking YopE (compare ‘‘E þ T’’ to ‘‘T,’’ Figure 7A and 7C),
although the levels of activation were somewhat higher than
that seen for a single infection with the YopE-expressing
strain (Figure 7A and 7C). In contrast, the effects of YopE on
the host cell could be totally blocked by the presence of
YopT, if the strain expressing YopT was allowed to incubate
with the cells for 30 min prior to the addition of the YopE-
containing strain (Figure 7B and 7C). Therefore, the presence
of YopT in the cytoplasm of host cells clearly interfered with
the activity of YopE. During conditions of simultaneous
infection, however, YopE could efﬁciently compete with
YopT to cause inactivation of Rac1. This result is supported
by the behavior of IP32953, which showed efﬁcient inactiva-
tion of cytoplasmic pools of Rac1 although the strain encodes
YopT (Figure 7A).
Despite the fact that cytoplasmically-localized Rac1 was
inactivated in cells simultaneously exposed to YopT and
YopE, YopT still exerted effects on these cells. Nucleus-
localized Rac1 could be detected for any experimental
procedure that introduced YopT into cells, even if a YopT-
expressing strain was added 30 min after the addition of the
YopE expressing strain (‘‘E ! T,’’ Figure 7D). This result was
not due to lowered YopE translocation, as all infection
strategies resulted in efﬁcient translocation of YopE (Figure
7E). It appears that the combined effects of YopE and YopT
on a single cell are to inactivate Rac1 in the cytoplasm, and
promote translocation of Rac1 into the nucleus.
As the YopT-cleaved Rac1 may be protected from YopE
and come in contact with Rac1-speciﬁc guanosine exchange
factor (RacGEF) proteins in the nucleus [22,30], the activation
of Rac1 was measured in the nucleus, normalizing FRET to
the concentrations of both Rac1 and PBD in this compart-
ment [33]. This normalization strategy clearly detected
activation in this compartment, and it was dependent on
both GTP loading of Rac1 (N17, Figure 8A) and binding of
Figure 4. Y. pseudotuberculosis YopT Removes Multiple Rho Family
Members from Nascent Phagosomes
(A–D) COS1 cells transfected with plasmids encoding T7-Rac1, T7-
Rac1C189S, myc-Cdc42, myc-RhoA, or HA-Arf6 were incubated at 37 8C
for 30 min with Y. pseudotuberculosis YP17 (A and C) or YP17/pYopT (B
and D) grown under described conditions (Materials and Methods). (A
and B) To identify nascent phagosomes, bacteria were probed as
described (Materials and Methods), and small GTPases were identified by
immunoprobing against appropriate tags. Pink identifies the extracellular
region of a bacterium and blue represents the internalized region. Green
indicates the staining for small GTPases. (C and D) Quantifications of the
percentage (mean 6 SEM in triplicate) of partially internalized bacteria
that stained positively for Rac1 (n ¼ 33), Cdc42 (n ¼ 33), RhoA (n ¼ 33),
Rac1C189S (n ¼ 33), or Arf6-HA (n ¼ 11).
(E) Representative localization of uninfected cells expressing mYFP-
Rac1(WT), mYFP-Rac1C189S, or mYFP-Rac16Q, as well as a mYFP-
Rac1(WT) transfectant challenged with YP17/pYopT for 30 min (WT;
þYopT). White bar represents 1 lm.
(F) The presence of excess RhoGDI interferes with the activity of YopT. Y.
pseudotuberculosis YP17/pYopT (þpYopT) was introduced for 30 min
onto COS1 cells or transfectants overexpressing RhoGDI. Nuclear
localization of Rac1 (defined as the ratio of the mean nuclear Rac1
intensity relative to the mean cytoplasmic Rac1 intensity) was
determined in each case.
DOI: 10.1371/journal.ppat.0010016.g004
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Spatial Modulation of Rac1 by YersiniaRac1 to PBD (C40, Figure 8A). Similarly, strong activation of
Rac1 in the nucleus could be detected if YopT were present,
no matter what infection conditions were used (Figure 8B).
Most signiﬁcantly, activated Rac1 was generated in the
nucleus by the clinical strain IP32935, which expresses YopT
and YopE (Figure 8B and 8C), even though incubation with
this strain efﬁciently inactivated the cytoplasmic pool of Rac1
(see Figure 7A). Therefore, simultaneous deposition of both
YopT and YopE acted to generate two pools of Rac1 in the
cell: an inactive pool in the cytoplasm and an active pool in
the nucleus.
Discussion
Enteropathogenic Yersinia sends contradictory signals that
control the activation status of Rho GTPases. The most
signiﬁcant result from these studies is that the locale of Rac1
within the host cell was shown to be an important determinant
of how the microorganism manipulates GTP loading. Engage-
ment of integrin receptors by the Y. pseudotuberculosis invasin
protein results in activation of Rac1, but activation was
localized around phagosomal cups that harbored Y. pseudotu-
berculosis strains lacking antagonizing Yop proteins (see Figure
2) [10]. Similarly, appropriate localization of Rac1 was
required for YopE to effectively block GTPase activation. In
contrast, misregulation by YopT was tightly associated with
mislocalization of Rac1, with the consequence that the GTPase
was activated in the nucleus. Our FRET-based assay revealed
rapid inactivation of Rac1 by YopE (see Figure 3) that was
surprisingly limited to membrane-associated Rac1. Previous
results indicating that YopE localizes to perinuclear vesicles
after translocation do not explain why plasma membrane-
associated Rac1 should be selectively targeted by YopE [34].
Perhaps YopE is transiently associated with the plasma
membrane prior to vesicle-associated retrograde trafﬁcking
to a perinuclear compartment, where it encounters other Rho
Figure 6. Overexpression of YopT Interferes with YopE-Mediated
Inactivation of Rac1 by Blocking YopE Translocation
COS1 cells were cotransfected with plasmids expressing mYFP-PBD and
mCFP-Rac1, challenged for 30 min with Y. pseudotuberculosis strains YP15
(yopE
þ), YP15/pYopT (yopE
þyopT
þ) or YP17/pYopT (yopE
 yopT
þ) and
processed for FRET analysis as in Figure 5 (Materials and Methods).
(A) Typical FRET images of cells incubated with denoted strains.
(B) The presence of pYopT interferes with the ability of YopE to inactivate
cytoplasmically localized Rac1. Data represent normalized FRET, using
ROIs within the cytoplasms of ten cells. ***** p , 5 3 10
 5;*p ¼ 0.01.
Normalized FRET was determined as described (Materials and Methods).
(C) Plasmid-expressed YopT promotes translocation of active Rac1 into
the nucleus in the presence of YopE. Nuclear accumulation of Rac1 was
determined by presence of mCFP-Rac1 fluorescence (bar graph), and
activation was determined in that population showing accumulation
using FRET analysis of nuclear regions (data below bar graph; Materials
and Methods).
(D) Overexpression of YopT blocks translocation of YopE from bacteria
into host cells. After 1 h of infection with Y. pseudotuberculosis strains at
MOI ¼ 50, 0.5 3 10
6 COS1 cells were extracted with 0.1% NP-40 and
separated into soluble and pellet fractions to identify translocated YopE
in the soluble fraction (Materials and Methods). One-sixth of the soluble
fraction and one-half of the pellet were analyzed by immunoblotting
using an anti-YopE antibody. Strains used were as in (A), with the
addition of the yscU mutant, defective for type III secretion as a negative
control.
DOI: 10.1371/journal.ppat.0010016.g006
Figure 5. YopT Cleavage Does Not Prevent Rac1 Activation
COS1 cells were cotransfected with plasmids expressing mYFP-PBD and
either mCFP-Rac1 or mCFP-Rac1C189S followed by exposure to Y.
pseudotuberculosis for 30 min (Materials and Methods) and FRET analysis
in cytoplasmic ROIs.
(A–C) Cells expressing mCFP-Rac1(WT) challenged with either YP17
(control) (A) or mCFP-Rac1(WT) challenged with YP17/pYopT (þYopT) (B).
Rac1 activation is maintained in the presence of YopT cleavage (C). Data
for normalized Rac1 activity from eight cells described in (A) and (B) were
quantitated as mean 6 SEM.
(D) Cytoplasmic localization of Rac1 does not affect activation. FRET was
analyzed in ROIs from cytoplasmic regions of uninfected cells transfected
with mCFP-Rac1(WT) or mCFP-Rac1C189S and normalized versus amount
of mCFP observed in each cell. NS, no significant difference between
control and experimental.
(E) Example of normalized FRET observed in uninfected cell expressing
mCFP-Rac1C189S. White bar represents 10 lm.
DOI: 10.1371/journal.ppat.0010016.g005
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localized Rac1 to the nucleus indicates that there is a novel
role for YopT in sending activated proteins into this
compartment (see Figure 6). As both effectors targeted the
same pool of Rac1, mislocalization of Rac1 by YopT interfered
with the ability of YopE to inactivate Rac1, indicating a
potential novel role for YopT.
All standard criteria, including the use of Rac1 dominant
inhibitory mutants and effector binding-defective derivatives,
indicate that our FRET system faithfully monitored the
localization of Rac1 activation within the cell and gave
activation readouts similar to previously described analysis
(see Figure 1) [23]. Our results speciﬁcally concerning the
mutant-activated Rac1V12 form, however, did differ from a
previous report [13]. The relative amount of FRET produced
by Rac1V12 at sites having concentrated Rac1 in the
membrane was reported to be higher than at other sites in
the cell, even when normalized for the increased concen-
tration of Rac1 found at these sites. The contrasting results
are almost certainly due to the amount of RhoGDI relative to
RacV12 in the two studies, as the binding of RhoGDI to
soluble RacV12 interferes with binding to PBD, lowering the
FRET readout in cytoplasmic regions expressing relatively
Figure 8. Nuclear Localization of Rac1 Protects It from Inactivation by
YopE
COS1 cells expressing the probes for Rac1 activity (mCFP-Rac1 and
mYFP-PBD) were challenged with the indicated strains and then analyzed
for nuclear-localized Rac1 activation using FRET. To account for
differences in PBD and Rac1 concentrations in the nucleus relative to
the cytoplasm, FRET was normalized to both proteins (Materials and
Methods).
(A) The FRET readout in the nucleus requires Rac1 activation. Trans-
location of various mutants of mCFP-Rac1 was promoted by incubating
COS1 cells with YP17/pYopT2 for 30 min.
(B) YopE is not able to reverse or prevent the accumulation of active
nuclear Rac1 promoted by YopT. Control, 30-min incubation with YP17
(yopE
 yopT
 ); Control ! E, 30-min incubation with YP17 (yopE
 yopT
 )
followed by 30-min incubation withYP15 (yopE
þyopT
 ); E þ T, 30-min
coinfection withYP15 (yopE
þyopT
 ) and YP17/pYopT2 (yopT
þyopE
 ); T,
30-min incubation with YP17/pYopT2 (yopT
þyopE
 ); and T ! E, 30-min
incubation with YP17/pYopT2 (yopE
 ) followed by 30-min incubation
withYP15 (yopE
þyopT
 ).* * * * *p , 5 3 10
 5 relative to control
incubation.
(C) IP32953 inactivates cytosolic Rac1 and activates nuclear Rac1. Two
examples of cells infected with IP32953 for 1 h show intense Rac1 activity
(displayed as Nuclear FRET) that corresponds to the nucleus shown in
phase contrast images.
DOI: 10.1371/journal.ppat.0010016.g008
Figure 7. Temporally Regulated Interference of YopE Activity by YopT
COS1 cells cotransfected with mCFP-Rac1 and mYFP-PBD were incubated
with the noted strains and processed for FRET analysis using ROIs located
within the cytoplasm as in Figure 6 (Materials and Methods).
(A) YopE can inactivate cytosolic Rac1 in the presence of YopT. FRET was
determined after 30 min of infection with COS1 cells for the following
strains. E, YP15 (yopT
 yopE
þ); IP32953, clinical isolate expressing both
YopT and YopE; T, YP17/pYopT2 (yopT
þyopE
 ); and E þ T, mixed
infection of YP17/pYopT2 (yopT
þyopE
 ) and YP15 (yopT
 yopE
þ) added
simultaneously to cells.
(B) Injection of YopT prior to YopE interferes with Rac1 inactivation by
YopE. Control ! E, cells were infected with YP17 for 30 min and then
incubated with YP15 (yopE
þ) for 30 min; IP32953, cells were incubated
with clinical strain IP32953 (yopT
þyopE
þ) for 1 h; and T ! E, YP17/
pYopT2 (yopE
 ) was introduced onto cells for 30 min prior to incubation
of YP15 (yopE
þ) with cells for 30 min more. ***** p , 5 3 10
 5;* *p ¼
0.002. Results from eight cells were quantitated as mean 6 SEM.
(C) Examples of sensitized FRET and normalized FRET for cells infected
with denoted strains, as above.
(D) YopT-promoted Rac1 nuclear localization occurs after YopE pretreat-
ment. COS1 cells were incubated with bacteria using the above
conditions, with the added protocol of incubating the cells with bacteria
expressing YopE for 30 min prior to infection with bacteria that express
YopT. E ! T, YP15 (yopE
þyopT
 ) was introduced onto cells for 30 min,
prior to incubation of YP17/pYopT2 (yopT
þyopE
 ) with cells for 30 min
more. Results are displayed from the analysis of ROIs in eight to ten cells,
with measurement of the nuclear localization index for Rac1 (ratio of
Rac1 in the nucleus to that in the cytoplasm; Materials and Methods).
(E) Translocation of YopE is unaffected by the presence of YopT in either
a serogroup I strain or using coinfection conditions. Infection conditions
were as indicated above; translocation was assayed, and the amount of
protein was determined by immunoblotting using an anti-YopE antibody
in an NP-40 extractible fraction (Materials and Methods). Pellet, protein
not extracted by NP40 (associated with bacterial pellet); Soluble, NP40-
soluble fraction (translocated).
DOI: 10.1371/journal.ppat.0010016.g007
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Spatial Modulation of Rac1 by Yersiniahigh levels of RhoGDI [13]. Consistent with this interpreta-
tion, we found that overexpression of RhoGDI greatly
attenuated cytoplasmic FRET from mCFP-Rac1V12 to
mYFP-PBD (unpublished data). We think it is highly unlikely,
however, that our data on localization of mCFP-Rac1(WT)
activation were dependent on levels of RhoGDI in our cell
line. Activation of mCFP-Rac1(WT) was independent of the
concentration of mCFP-Rac1, indicating that even at the
lowest levels of Rac1 expression there were enhanced levels of
GTP loading at the phagosomal cup compared to other sites
in the cell (see Figure 2E).
A signal that induces the release of Rac1 from RhoGDI is
t h eﬁ r s ts t e pi na c t i v a t i o na f t e ri n t e g r i ne n g a g e m e n t ,
followed by GTP loading by guanine nucleotide exchange
factors and translocation of Rac1 to the membrane [13].
During invasin-promoted uptake, these events could occur
sequentially, or be coupled to each other in a concerted
process involving a RacGEF. Dock180 is a RacGEF that is a
likely candidate for involvement in this process, as it has been
implicated in both integrin-dependent activation events and
in phagocytosis [36,37]. This protein is recruited to complexes
resulting from tyrosine phosphorylation cascades that occur
subsequent to integrin engagement [38]. In fact, high
efﬁciency invasin-promoted uptake requires tyrosine phos-
phorylation, but there is considerable bacterial uptake even
in the presence of tyrosine kinase inhibitors [39]. Therefore,
we favor a model in which there are multiple pathways
leading to Rac1 activation after bacterial binding, some of
which may involve tyrosine kinase cascades.
It has been argued that misregulation of the host cell
cytoskeleton by the Yersinia translocated effectors is a two-
step process that involves Rac1 inactivation followed by
removal of the protein from the membrane after integrin
engagement. RhoGDI removes Rac1-GDP from the mem-
brane, preventing reactivation and coupling of Rac1 with
downstream effectors [35]. This extraction process may be
required for bacterial RhoGAP proteins (such as YopE) to
mediate wholesale cytoskeletal changes, because cell round-
ing induced by the RhoGAP homolog ExoS from P. aeruginosa
is dependent on the presence of RhoGDI [40]. It is possible
that most Yersinia strains bypass the necessity for using such a
host factor to extract YopE-inactivated Rac1, because YopT
cleavage results in removal of Rac1 from the membrane,
giving the potential for the two virulence factors to work in
concert (discussed below). The reason that removal from the
membrane is important is not clear, but Rac1-GDP present in
the membrane may be transiently reactivated, reversing the
effects of the RhoGAP.
Rac1 released from the plasma membrane by YopT
resulted in an active pool of the GTPase within the nucleus
(see Figures 4 and 8), consistent with the notion that the
polybasic C terminus of Rac1 acts as a nuclear localization
signal when the prenylation site is removed [22]. In the
experiments described here, this proteolysis interfered with
the activity of YopE (see Figure 7B). Such interference would
appear to be counterproductive, with YopT ruining the
effects of YopE on the host cell. However, the behavior of the
Y. pseudotuberculosis I strain IP32935 clariﬁes this relationship,
as the competition between YopT and YopE is not an all-or-
none process. During incubations with this strain, a pool of
activated and nucleus-localized Rac1 was generated while the
cytoplasmic pool of Rac1 was inactivated. Therefore, the
combined action of YopT and YopE generated two spatially
distinct pools of Rac1 having different activation states (see
Figures 7 and 8), allowing ﬁne-tuning of the activation
properties of the GTPase. It is interesting to note that this
strategy may be important for only some Yersinia species, or
for causing disease in only a subset of mammalian hosts.
Although YopT is expressed in most of the known Y. pestis and
Y. enterocolitica strains, the situation is less clear-cut with Y.
pseudotuberculosis, in which clinical isolates such as YPIII lack
expression of YopT. For these strains, or for the hosts in
which they grow, nuclear localization of Rac1 may not be
important, and may even interfere with the disease process.
In fact, the presence of YopT was observed to reduce
virulence of Y. enterocolitica in the mouse [41]. This result is
presumably not true for all hosts, as there must be some
selection for retention of this translocated protein. Alter-
natively, YopT may be important for a process other than
acute disease, such as maintaining a persistent infection.
Although competition between YopT and YopE can be
observed in this work, it is possible that the two proteins have
a collaborative relationship that is more difﬁcult to measure.
YopT could collaborate with YopE by releasing Rac1-GDP
from the membrane after YopE action but prior to that of
RhoGDI, causing accumulation of inactive Rac1 in the
nucleus. This should bypass any need for RhoGDI to support
the function of YopE as previously reported [40]. The
activation state of Rac1 in the nucleus could then be
controlled by GEFs in this compartment.
As a ﬁnal note, the translocation of Rac1 into the nucleus
that results from YopT cleavage may be a strategy to cause
misregulation of the host cell transcription program. As the
nuclear Rac1 population includes active protein, it is able to
bind downstream effectors. Furthermore, it is known that
several GEFs, such as SmgGDS and Dock180, can be similarly
localized in this compartment, maintaining Rac1 in the active
conformation to bind nuclear factors [22,30]. One such factor
that interacts with Rac1-GTP is STAT3 (signal transducer and
activator of transcription 3) [42]. This transcription factor
controls interleukin-10-dependent suppression of macro-
phage activation, so YopT-induced translocation of activated
Rac1 into the nucleus may prevent macrophage activation,
even in the absence of an external interleukin-10 signal [43].
The ability to measure the activation levels of Rho family
members in response to bacterial binding to host cells, and
determine the effects of misregulation on inﬂammatory
responses, should facilitate future studies on the potentially
competitive roles of Yersinia translocated effector proteins.
Materials and Methods
Cell culture, DNA constructs, and transfections. COS1 cells were
cultured and transfected as previously described [10]. Plasmids
pmECFP-N1 and pmEYFP-N1 containing the L211K mutations in
CFP and YFP, which prevent dimerization and reduce the probability
of false-positive FRET, were generated by QuikChange site-directed
mutagenesis (Stratagene, La Jolla, California, United States) using
pECFP-C1 and pEYFP-C1 (Clontech, Palo Alto, California, United
States) as templates [26]. T7 epitope-tagged pCGT-Rac1, pCGT-
Rac1V12, and pCGT-Rac1N17 were described [14]. The human Rac1
cDNAs were isolated from these plasmids and inserted directly
downstream from the 39 end of CFP located in pmECFP to create
pmCFP-Rac1(WT), pmCFP-Rac1V12, and pmCFP-Rac1N17 (see Ta-
ble 1 for summary of derivatives). The Rac1 Y40C, R66A, or C189S
mutations were introduced into pmCFP-Rac1(WT) or pmCFP-
Rac1V12 by site-directed mutagenesis using the QuikChange proto-
PLoS Pathogens | www.plospathogens.org October 2005 | Volume 1 | Issue 2 | e16 0134
Spatial Modulation of Rac1 by Yersiniacol. The pmYFP-PBD and pmYFP-PBD(LL) plasmids were generated
by PCR amplifying the region encompassing residues 67–118 of
human PAK1 cDNA from pCMV6M-Pak1 and pCMV6M-Pak1(LL)
(H83L, H86L), kindly by provided by J. Chernoff (Fox Chase Cancer
Center, Philadelphia, Pennsylvania, United States), and then fusing
the product to the 39 end of YFP of pmEYFP. All plasmids were
veriﬁed by DNA sequencing. The mammalian expression vectors that
express N-terminal myc-tagged RhoA and myc-tagged Cdc42 were
provided by K. Wong (University of California at San Francisco, San
Francisco, California, United States) and Rac16Q by U. Knaus
(Scripps, San Diego, California, United States). The bacterial
expression vector pYopE was described previously [14]. pYopT,
which encodes Y. pseudotuberculosis serogroup I YopT under the strong
YopH promoter, was a kind gift from J. Bliska (The State University of
New York, Stony Brook, New York, United States). Y. pseudotuberculosis
pYPIII(P
 ) is a serogroup III strain cured of the virulence plasmid and
that lacks the YadA protein. Y. pseudotuberculosis strain YP17
(YPIII[pYV
þ] yopT
  yopE::kan yopH::cam), lacks three translocated
effectors but has an intact type III secretion system. Y. pseudotubercu-
losis strain YP15 (YPIII[pYV
þ] yopT
  yopH::cam)i sayopE
þ derivative
of YP17. The strain IP32935, a kind gift from E. Garcia (Lawrence
Livermore National Laboratory, Berkeley, California, United States),
is a serogroup I clinical isolate that has recently been sequenced and
encodes both YopT and YopE on its virulence plasmid [32].
Y. pseudotuberculosis infection of mammalian cells and immuno-
ﬂuorescence staining of bacteria. Growth conditions of YPIII(P
 ) were
used such that invasin was the only protein expressed that promoted
attachment to host cells. Bacteria were grown on LB-agar plates,
supplemented with 100 lg/ml ampicillin when necessary, at 26 8C for
2 d. The day before infection, a single colony was grown with aeration
at 26 8C overnight in LB broth containing 100 lg/ml ampicillin as
necessary, and then subcultured in broth with aeration until A600 ¼
0.7. For YP15 and YP17 strains, subcultures of the overnight cultures
were performed in broth supplemented with 2.5 mM CaCl2 and
grown at 26 8C until A600 ¼ 0.2. At this point, the cultures were then
shifted to 37 8C and aerated for 1 h. A multiplicity of infection (MOI)
¼ 50:1 was used for YPIII(P
 ) incubations, and an MOI of 25:1 was
used for YP17 derivatives. For YP17/pYopE, 0.1 mM isopropyl-b-D-
thiogalactopyranoside was supplemented during infection to induce
YopE expression.
COS1 cells incubated with bacteria were processed for immuno-
ﬂuorescence staining using anti-Y. pseudotuberculosis as described [10],
revealing extracellular bacteria with anti-rabbit IgG-Texas Red
(Molecular Probes, Eugene, Oregon, United States) and total bacteria
with goat anti-rabbit IgG-Cascade Blue (Molecular Probes) after
ﬁxation with 3% paraformaldehyde.
To detect localization of Rac1, Cdc42, or Arf6-HA, cells were
stained using mouse monoclonal antibodies directed against Rac1,
Cdc42 (BD Transduction Laboratories, San Diego, California, United
States), or the HA tag (Santa Cruz Biotechnology, Santa Cruz,
California, United States) followed by probing with goat anti-mouse
IgG-Alexa Fluor 488 (Molecular Probes). To analyze partially engulfed
organisms, bacteria were identiﬁed in which only a portion of the rod
showed staining with anti-Y. pseudotuberculosis in the absence of
permeabilization [14]. To determine the extent of Rac1 accumulation
in the nucleus, images were captured from single cells, and the mean
intensity values of the nucleus as well as that of the cytoplasm were
determined. The Rac1 nuclear localization index was then deﬁned as
the ratio of the two intensity values (mean nuclear intensity divided
by mean cytoplasmic intensity) from eight to ten cells.
FRET image analysis to determine levels of Rac1 activation. To
determine levels of Rac1 activation within COS1 cells, monolayers
grown on 12-mm untreated round glass coverslips (Fisher Scientiﬁc,
Pittsburgh, Pennsylvania, United States) were washed three times in
PBS, ﬁxed in PBS containing 3% paraformaldehyde, and then
immunostained, if appropriate. The coverslips were then mounted
on glass slides in the presence of antifade reagent (BioRad, Hercules,
California, United States). Individual cells were analyzed using a Plan
Apo 1003/1.4 objective ﬁtted on a Nikon Eclipse TE300 inverted
microscope (Nikon, Tokyo, Japan) with a 100-W Hg light source,
using neutral density ﬁlter-4 (25% transmittance). Images were
captured using a Hamamatsu Orca II camera (Hamamatsu Photonics,
Hamamatsu City, Japan), with scripts controlled by IPLab v 3.5
software (Scanalytics, Rockville, Maryland, United States) capturing,
in order, the YFP, CFP, and FRET channels at a bin setting of 2 3 2
with 200 msec exposure time. Filter sets (Chroma, Rockingham,
Vermont, United States) consisted of: YFP excitation/emission set
with HQ500/203 (exciter), Q515LP (beamsplitter), and HQ535/30m
(emitter) ﬁlters; CFP excitation/emission set, with D436/103,
455DCLP, and D480/40m ﬁlters; and a FRET set, with D436/103,
455DCLP, and HQ535/30m ﬁlters. Photobleaching of YFP was
performed using the D535/50 excitation ﬁlter and a Q515LP
beamsplitter (Chroma).
The ROI chosen to determine FRET was dependent on whether or
not transfectants were incubated with bacteria. For all experiments in
which transfectants were incubated in the absence of bacteria, two
random ﬁelds (each about 10% of the area of a whole cell) located
within cytoplasmic regions were chosen. Nucleus-localized protein
was avoided, unless stated otherwise. To determine the amount of
FRET surrounding nascent phagosomes, the ROI chosen was around
partially internalized bacteria [14]. In cases in which the amount of
normalized FRET in the area proximal to the phagosomes was
compared to elsewhere in the cytoplasm of the same cell, a single ROI
of the COS1 cytoplasm, which was near the nascent phagosome and
encompassed a similar-sized area to that of the nascent phagosome,
was chosen as the normalized FRET control.
To quantitate sensitized FRET, correction coefﬁcients were
derived to account for bleedthrough of CFP emission and cross-
excitation of YFP during FRET measurements. The background level
of ﬂuorescence on the coverslip was determined, and then cells that
were singly transfected with either mCFP-Rac1 or mYFP-PBD were
analyzed. The correction coefﬁcient for a particular ﬂuor was
determined by capturing images from the singly transfected cells.
The mean intensities (I) from two randomly-chosen cytoplasmic
regions of interests from single cells were determined, and the
fraction of emission observed with the FRET ﬁlter relative to the
appropriate excitation/emission ﬁlter set (IFRET ﬁlter/Iﬂuor ﬁlter) was
calculated. The coefﬁcient of CFP bleedthrough emission into the
FRET emission ﬁlter (IFRET ﬁlter/ICFP ﬁlter) was approximately 0.39, and
the coefﬁcient of YFP cross-excitation by the FRET excitation ﬁlter
(IFRET ﬁlter/IYFP ﬁlter) was 0.22. For a sample, sensitized FRET was
typically calculated as Isensitized FRET ¼ IFRET   (0.39 3 ICFP)   (0.22 3
IYFP) [33]. In certain cases, normalized FRET was determined, which
was the ratio of FRET relative to the concentration of mCFP-Rac1 at
individual sites within the cell. Images of normalized Rac1 activation
were obtained by ﬁrst constructing sensitized FRET images and
masking them, so that all of the non-cell pixels had zero FRET
intensity. Then the resulting images were divided by those obtained
using the CFP ﬁlter. To account for the dramatic differences in the
relative concentration of PBD and Rac1 in the nucleus after YopT
treatment, we normalized FRET signal from nucleus to both proteins
by calculating nuclear FRET as Isensitized FRET/(ICFP 3 IYFP)
1/2 as
described previously [33].
Photobleaching was determined after grabbing the images re-
quired for FRET determinations. The sample was the exposed for 3
min to a 100-W Hg lamp using a 535 nm excitation ﬁlter but no
neutral density ﬁlter. An image was then grabbed using the CFP ﬁlter
set. Images obtained before and after photobleaching were back-
ground subtracted, and the CFP ﬂuorescence in two ROIs from each
image were obtained to calculate the percentage increase in CFP
emission.
Detergent fractionation of COS1 cells infected with Y. pseudotu-
berculosis for Yop translocation. Freshly diluted Y. pseudotuberculosis
was grown in LB broth with antibiotic if necessary, as above, at 26 8C
for 2 h, transferred to 37 8C, and grown for a further 2 h. The bacteria
were then incubated at MOI¼50 for 0.5 or 1 h with COS1 cells (0.53
10
6) grown in 10-cm
2 dishes. After one wash with PBS, infected cells
were incubated for 20 min at 4 8C with 400 ll of lysis buffer (150 mM
NaCl, 0.1% NP-40, and 10 mM NaH2PO4) containing 200 lM AEBSF,
10 lg/ml leupeptin, and 10 lg/ml pepstatin. Lysed cells were collected
and centrifuged for 10 min at 13,000 rpm at 4 8C, and 133 ll of the
supernatant was taken and precipitated with 1:4 methanol-chloro-
form. The precipitated detergent-soluble proteins and the detergent-
insoluble pellets were resuspended and boiled in SDS-PAGE sample
buffer containing 5% SDS. Half of the soluble and pellet samples
were analyzed by SDS-PAGE and immunoblotted using an antibody
against YopE, provided by J. Mecsas (Tufts University, Massachusetts,
United States).
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